Connie Jo Hansen

USPTO Granted Patents = 19 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 254(Granted Patents)

Company Filing History:

10 out of 4,667

Agilent Technologies, Inc.

Stratagene California

Bp Corporation North America Inc.

patents

6. 1 out of 832,680

Other

patents

Years Active: 1997-2024

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12006519 - Polymerase mutants and use with 3'-OH unblocked reversible terminators (2024-06-11),

2. 11773380 - Polymerase mutants and use with 3'-OH unblocked reversible terminators (2023-10-03),

3. RE49207 - Transposase-random priming DNA sample preparation (2022-09-12),

4. 10240196 - Transposase-random priming DNA sample preparation (2019-03-26),

5. 9758773 - Thermostable type-A DNA polymerase mutant with increased resistance to inhibitors in blood (2017-09-12),

6. 9523085 - Thermostable type-A DNA polymerase mutants with increased polymerization rate and resistance to inhibitors (2016-12-20),

7. RE45660 - Xylanases, nucleic acids encoding them and methods for making and using them (2015-08-31),

8. 9085762 - Compositions and methods using split polymerases (2015-07-21),

9. 8772006 - Compositions and methods utilizing DNA polymerases (2014-07-08),

10. 8268605 - Compositions and methods utilizing DNA polymerases (2012-09-18),

11. 8043839 - Xylanases, nucleic acids encoding them and methods for making and using them (2011-10-25),

12. 7943358 - Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying (2011-05-17),

13. 7642079 - Proteases, nucleic acids encoding them and methods for making and using them (2010-01-05),

14. 7625725 - Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF proteins, and methods for purifying and identifying them (2009-12-01),

15. 7442766 - Pfu replication accessory factors and methods of use (2008-10-28),

Title: The Innovative Mind of Connie Jo Hansen: Revolutionizing Genetic Analysis

Introduction: Connie Jo Hansen, a prolific inventor based in San Diego, CA, has made significant contributions to the field of genetic analysis with a remarkable portfolio of 18 patents to his name.

Latest Patents:

1. Polymerase mutants and use with 3'-OH unblocked reversible terminators: Hansen's patented mutant polymerases are designed to improve the incorporation of modified nucleotides, specifically 3'-OH unblocked reversible terminators. These innovations find applications in polynucleotide sequencing, primer extension reactions, and enzymatic oligonucleotide synthesis.

2. Transposase-random priming DNA sample preparation: Hansen's method allows for the tagging and amplification of short DNA fragments (ranging from about 150 bp to 1.5 Kb) using transposase-mediated techniques. The process involves barcoding DNA fragments with a first primer sequence using transposases, followed by a primer extension to introduce a second primer sequence.

Career Highlights: Connie Jo Hansen has left a significant mark in the industry through his tenure at renowned companies such as Agilent Technologies, Inc. (Agilent) and Stratagene, where he honed his skills and developed groundbreaking technologies.

Collaborations: During his career, Hansen has collaborated with esteemed professionals in the field, including Holly Hogrefe and Jeffrey Fox, to bring his innovative ideas to fruition and push the boundaries of genetic analysis further.

Conclusion: Connie Jo Hansen's inventive spirit and dedication to advancing genetic analysis have solidified his position as a trailblazer in the industry. With an impressive patent portfolio and a history of successful collaborations, Hansen continues to drive innovation and shape the future of genetic research.

This text is generated by artificial intelligence and may not be accurate.